We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Imaging Technique Offers Hope for Real-Time Histology

By LabMedica International staff writers
Posted on 13 Dec 2010
Researchers have used a novel microscope-based imaging technique to differentiate between cancer cells and normal cells in living tissue without the need for time-consuming histological procedures.

Investigators at the University of Illinois (Urbana-Champaign, USA) used lipid and protein specific microscopic probes in conjunction with a novel technique called nonlinear interferometric vibrational imaging (NIVI).

The probes were used to label lipid-rich normal cells and protein-rich cancer cells within living rat tissues. More...
By combining two different light sources, the microscope produced colored images that defined normal and cancerous areas within the tissue.

Results published in the November 23, 2010, online edition of the journal Cancer Research revealed that the technique was able to provide easy-to-read, color-coded images of the tissue, with more than 99% confidence, in less than five minutes. Particularly impressive was the technique's ability to outline tumor boundaries clearly.

"Sometimes it is very hard to tell visually whether a cell is normal or abnormal,” said senior author Dr. Stephen A. Boppart, professor of bioengineering and medicine at the University of Illinois. "But molecularly, there are fairly clear signatures.”

"The diagnosis is made based on very subjective interpretation - how the cells are laid out, the structure, the morphology,” said Dr. Boppart. "This is what we call the gold standard for diagnosis. We want to make the process of medical diagnostics more quantitative and more rapid. As we get better spectral resolution and broader spectral range, we can have more flexibility in identifying different molecules. Once you get to that point, we think it will have many different applications for cancer diagnostics, for optical biopsies, and other types of diagnostics.”

Related Links:
University of Illinois




Gold Member
Blood Gas Analyzer
Stat Profile pHOx
Collection and Transport System
PurSafe Plus®
New
Silver Member
PCR Plates
Diamond Shell PCR Plates
Hemodynamic System Monitor
OptoMonitor
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Urine samples can indicate lupus nephritis without the need for repeat and painful renal biopsies (Photo courtesy of Shutterstock)

Urine Test Could Replace Painful Kidney Biopsies for Lupus Patients

Lupus is an autoimmune disorder that causes the immune system to attack the body’s own tissues and organs. Among the five million people living with lupus globally, nearly half develop lupus nephritis,... Read more

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: When assessing the same lung biopsy sample, research shows that only 18% of pathologists will agree on a TCMR diagnosis (Photo courtesy of Thermo Fisher)

Molecular Microscope Diagnostic System Assesses Lung Transplant Rejection

Lung transplant recipients face a significant risk of rejection and often require routine biopsies to monitor graft health, yet assessing the same biopsy sample can be highly inconsistent among pathologists.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.